Standard Free Shipping | Free 2-Day Shipping (Orders $80+)

35% Off First-Time Subscription Orders | Code: PET35

Depression: Scientific Research & Clinical Trials

Antidepressant-like and anxiolytic-like effects of cannabidiol

Endocannabinoid system dysfunction in mood and related disorders.

Endocannabinoid signaling in the etiology and treatment of major depressive illness

The endocannabinoid system and the treatment of mood and anxiety disorders.

Antidepressant-like effects of cannabidiol in mice

Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants.

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

Serum contents of endocannabinoids are correlated with blood pressure in depressed women.

Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.

The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.

Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.

Prohedonic Effect of Cannabidiol in a Rat Model of Depression.